2022: Predictions for medical and healthcare industry
2022 is going to be the year of opportunities and innovations from the medical industry in India
2022 is going to be the year of opportunities and innovations from the medical industry in India
The U.S. FDA advisory committee voted 13-10 in favour of the oral antiviral medicine
The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly
A first for the Asian market, addressing the health spends needs of over 200 million households.
The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation
Two out of three people under the age of 40 are at risk of prediabetes
Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
Dupixent is the only biologic medicine to improve lung function in children aged 6 to 11 years in a randomized Phase 3 trial, supporting potential as a best-in-class option
In collaboration with RAND Europe, the Vitality calculator predicts an individual's healthspan and future health risks
Subscribe To Our Newsletter & Stay Updated